2020 - Fellow of the Indian National Academy of Engineering (INAE)
Angela Panoskaltsis-Mortari focuses on Immunology, Graft-versus-host disease, Transplantation, Stem cell and Immune system. Her work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Cell therapy. She has included themes like Hematopoietic stem cell transplantation, Blockade, Lymphatic system and Recombinant Granulocyte Colony-Stimulating Factor in her Graft-versus-host disease study.
Angela Panoskaltsis-Mortari interconnects Ex vivo, Cancer research, Spleen, Adoptive cell transfer and Leukemia in the investigation of issues within Transplantation. The concepts of her Stem cell study are interwoven with issues in Cell migration, Lung and Bone marrow, Pathology. Her biological study spans a wide range of topics, including Apoptosis and Growth factor, Keratinocyte growth factor.
The scientist’s investigation covers issues in Immunology, Graft-versus-host disease, Transplantation, T cell and Cancer research. Her Immunology research is multidisciplinary, incorporating elements of Cytotoxic T cell and Stem cell. Her Graft-versus-host disease research includes themes of Apoptosis, Germinal center, Spleen, Lymphatic system and Proinflammatory cytokine.
Her work deals with themes such as Inflammation and Tumor necrosis factor alpha, which intersect with Transplantation. Her T cell research is multidisciplinary, incorporating perspectives in Molecular biology, CD8 and Sirolimus. The concepts of her Cancer research study are interwoven with issues in Haematopoiesis, Leukemia and In vivo.
Angela Panoskaltsis-Mortari mainly focuses on Immunology, Transplantation, Internal medicine, Graft-versus-host disease and Immune system. Her Immunology study combines topics from a wide range of disciplines, such as Hematopoietic stem cell transplantation and Bronchiolitis obliterans. Angela Panoskaltsis-Mortari has researched Transplantation in several fields, including Clinical trial, Immunosuppression, Cyclophosphamide, Stem cell and Disease.
Her Internal medicine study incorporates themes from Gastroenterology and Oncology. Angela Panoskaltsis-Mortari focuses mostly in the field of Graft-versus-host disease, narrowing it down to matters related to Cancer research and, in some cases, Tumor microenvironment, Leukemia and Proinflammatory cytokine. As part of the same scientific family, Angela Panoskaltsis-Mortari usually focuses on T cell, concentrating on Cytotoxic T cell and intersecting with CD8 and Calcineurin.
Immunology, Transplantation, Internal medicine, Lung and Hematopoietic stem cell transplantation are her primary areas of study. Her studies deal with areas such as Cytotoxic T cell and Graft-versus-host disease as well as Immunology. Her Transplantation research includes themes of Peripheral blood mononuclear cell, STAT5, Disease, STAT3 and Major histocompatibility complex.
In her research, Hemodynamics, Ex vivo lung perfusion, Lung preservation and Lung surgery is intimately related to Pathology, which falls under the overarching field of Lung. She interconnects Bronchiolitis obliterans, Lymphoma, Rituximab and Donor selection in the investigation of issues within Hematopoietic stem cell transplantation. Angela Panoskaltsis-Mortari has included themes like Germinal center and Cell therapy in her Immune system study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney.
Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells
E. Ashley Moseman;Xueqing Liang;Amanda J. Dawson;Angela Panoskaltsis-Mortari.
Journal of Immunology (2004)
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
Patricia A. Taylor;Angela Panoskaltsis-Mortari;Jessica M. Swedin;Philip J. Lucas.
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Steven L. Highfill;Paulo C. Rodriguez;Qing Zhou;Christine A. Goetz.
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A Geller;Sarah A Cooley;Patricia L. Judson;Rahel G Ghebre.
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Daniel J. Weiss;Jay K. Kolls;Luis A. Ortiz;Angela Panoskaltsis-Mortari.
Proceedings of the American Thoracic Society (2008)
Development of a Decellularized Lung Bioreactor System for Bioengineering the Lung: The Matrix Reloaded
Andrew P. Price;Kristen A. England;Amy M. Matson;Bruce R. Blazar.
Tissue Engineering Part A (2010)
Leukocyte migration and graft-versus-host disease
Christian A. Wysocki;Angela Panoskaltsis-Mortari;Bruce R. Blazar;Jonathan S. Serody.
Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent Mechanism
Bruce R. Blazar;Beatriz M. Carreno;Angela Panoskaltsis-Mortari;Laura Carter.
Journal of Immunology (2003)
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Michael J. Carlson;Michelle L. West;James M. Coghill;Angela Panoskaltsis-Mortari.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: